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excluded. ICD-9 codes for hypertension (HTN), diabetes mellitus (DM),
cerebral vascular disease (CVA), spinal stenosis (SS), and herniated inter-
vertebral disc (HIVD) were used for disease conﬁrmation only when the
diagnoses existed at least one year before TURP. Descriptive and compar-
ative analyses were performed.
Results: There were 2597 TURPs analyzed, including 2497 TURPs only
(group A) and 100 TURPs with combined with TUIBN (group B). The hos-
pitalization days mainly ranged from 3 to 5 days. The mean age was 72.45,
with 72.69 and 71.86 in group A and B respectively. Among all patients
included, 245 of them were associated with AUR (9.43%), with 9.69% and
3.00% in group A and B (P¼ 0.022). Patient who had previous AUR episodes
within 2 months before TURP was of 23.64%, but pre-OP AUR was not
signiﬁcantly associatedwith higher post-OPAUR rate (11.24%) than no AUR
before TURP (8.88%) (P ¼ 0.083). About co-morbidities, HTN, DM, CVA, SS,
and HIVD were not signiﬁcant risk factors for AUR after TURP (P ¼ 0.934,
0.426, 0.111, 0.976, and 0.362 respectively). In multivariate analysis, com-
bined TUIBN and younger age are the only two signiﬁcant factors associ-
ated with less AUR rates after smaller weight TURPs. (P ¼ 0.041 and 0.028
respectively)
Conclusion: In Taiwan, most patients treated with smaller weight TURP
without combined TUIBN. However, AUR rate is signiﬁcantly lower in pa-
tients receiving combined TURP with TUIBN, regardless of pre-OP Foley
indwelling or other co-morbidities. Although further randomized clinical
trials are still necessary, it implies that for patients with bladder outlet
obstruction treated with smaller resection weight of TURP, combined
TUIBN may be beneﬁcial, especially regarding the post-OP AUR episodes.
NDP036:
THE IMPACT OF PSEUDEPHEDRINE ON LOWER URINARY TRACT
SYMPTOMS IN MALE PATIENTS WITHOUT CONCOMITANT VOIDING
DYSFUNCTION
I-Hung Shao 2, Hueih-Shing Hsu 2, Shyh-Chyi Chang 2, Hsu-Hsiang
Wang 2, Heng-Chang Chuang 2, Yuan-Yun Tam1. 1Division of Urology,
Poh-Ai Hospital, Lotung, Yilan, Taiwan; 2Division of Otolaryngology, Poh-Ai
Hospital, Luodong, Yilan, Taiwan
Purpose: Pseudoephedrine is a widely used sympathomimetic amine on
patients with rhinorrhea and allergic rhinitis. The vasoconstriction effect is
believed to be principally an on a-adrenergic receptor response. Urinary
retention was considered contraindication while use on patients with
concomitant prostatic hypertrophy needs precautions. Although not one of
the most seen overall side effects, patients suffered from urinary retention
or dysuria after taking pseudoephedrine may come to urologists for help.
The study aimed to elucidate the impact of pseudephedrine on lower
urinary tract symptoms (LUTS) in patients without self-reported voiding
dysfunction.
Materials and Methods: All male patients came to our Otolaryngology
OPD for acute or chronic rhinitis was asked by doctors to make sure they
are free from voiding dysfunction by self-reported. Then patients with
voiding problems or under current medication treatment for LUTS were
excluded. Other patients were given medication according to the indi-
vidual clinical symptoms. Once pseudoephedrine was prescribed, Inter-
national Prostate Symptom Score (IPSS) questionnaires were ﬁlled in by
the patients. After treatment with pseudoephedrine for 1 week, a post-
medication IPSS questionnaire was ﬁlled for follow-up. Total 68 patients
complete the survey. Age, IPSS total score, IPSS voiding score, IPSS voiding
score, quality of life score were analyzed for correlation.
Results: The average age of total 68 patients was 38.7 year-old (15-71
year-old). The average IPSS total score before and after medication was
4.81 and 6.54 respectively. The average IPSS voiding / storage score
before medication were 2.53/2.35 and changed to 3.68/2.87 after medi-
cation. Quality of life score based on voiding condition were 1.88 and
2.03 before and after medication. Independent T-test was used to eval-
uate the predictors for worsen (deﬁned as increased IPSS-T) and stable
(deﬁned as equal or decreased IPSS-T) voiding condition. Age, pre-
medication IPSS-T and IPSS-V were signiﬁcant predictors for worsen
voiding function after taking pseudoephedrine. Quality of life score based
on voiding condition before and after medication showed no signiﬁcantly
difference.Conclusion: Patients who were self-reported free from voiding dysfunc-
tion may still suffer from increased LUTS after pseudoephedrine. Age and
pre-medication IPSS-V score could be predictors for the presence of
increased LUTS.
NDP037:
SURGICAL TREATMENT OF KETAMINE-ASSOCIATED ULCERATIVE
CYSTITIS: 8-YEAR EXPERIENCE AT CATHAY GENERAL HOSPITAL AND
REVIEW OF SERIES
Chu-Hsuan Hung, Chih-Ming Lin. Division of Urology, Department of
Surgery, Cathay General Hospital, Taiwan
Purpose: To review clinical outcomes of bladder augmentation with
ileocystoplasty for ketamine-associated ulcerative cystitis secondary to
long-term ketamine abuse.
Materials and Methods: We performed bladder augmentation with ileo-
cystoplasty for 8 patients with refractory symptoms of ketamine cystitis
(severe bladder pain, micturition pain, urgency, frequency, and/or urinary
tract damage such as hydronephrosis, and contracted bladder). Every pa-
tient had been treated conservatively with medication at OPD or referred
from other hospital. Intravenous pyelography and/or cystoscopy were
obtained before they had received surgical intervention. Their history of
ketamine consumption, symptoms, history of treatment, surgical infor-
mation and post-operative condition was obtained from medical records
and then summarized.
Results: Between 2007 and 2015, eight patients (seven males and one
female), aged 26-48 years (mean 32.7 years) underwent this procedure as
indicated. The duration of ketamine abuse ranged from 2-15 years (mean
6.8 years). Contracted bladder was noted in all patients, hydronephrosis in
2 and hydroureter in 1 under intravenous pyelography examination. Post-
operative hospitalization ranged from 12-47 days (mean 22.4 days). One
patient had ileus post colono-enteric bypass post-operative within 90
days. One had impaired renal function before surgery and received inter-
mittent hemodialysis 5 years after surgery. Most of patients followed up at
OPD within 1 year and loss follow-up after. All patients reported marked
improvement in micturition pain and urinary frequency, which greatly
enhance their quality of life.
Conclusion: This study demonstrated that bladder augmentation is
effective in relieving refractory symptoms of ketamine-associated ul-
cerative cystitis. Cessation of ketamine is the most important way to
prevent recurrence of above symptoms. This is not only a medical issue,
but timely intervention of social workers and psychological support are
also essential.
NDP038:
LONG-TERM COMBINED a eBLOCKERS AND 5- a eREDUCTASE
INHIBITOR IN BPH-THERAPEUTIC EFFECTS, ADHERENCE, AND
PREDICTORS FOR WITHDRAWAL OF MEDICATION
Hueih Ling Ong 1, Chun Hou Liao 2, Hann-Chorng Kuo 1. 1Department of
Urology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan; 2Department
of Urology, Cardinal Tien Hospital and Fu-Jen Catholic University, New
Taipei, Taiwan
Purpose: To investigate the long-term therapeutic effects, patient adher-
ence of combination therapyof 5-a-reductase inhibitor (5ARI) and alpha-
blocker, and the predictors for withdrawal of medication in patients with
clinical benign prostatic hyperplasia (BPH).
Materials and Methods: BPH patients with lower urinary tract symptoms
(LUTS) under combination therapy were retrospectively analyzed from 1
to 12 years span. The therapeutics effects were assessed by International
Prostatic Symptoms Score (IPSS) and quality of life index (QoL-I), total
prostatic volume (TPV), maximum ﬂow rate (Qmax), voided volume
(VoL), prostatic speciﬁc antigen (PSA) at baseline and annually. The
reason and predictors of discontinued combination therapy were also
investigated.
Results: A total of 625 patients aged 38 to 97 (mean 73) years where
enrolled retrospectively with at least 1 year and the longest period of 12
years follow-up. The mean year follow up was 3 years. All measured pa-
rameters showed signiﬁcant improvement after combination therapy. The
Abstracts / Urological Science 26 (2015) S50eS81S60mean year of discontinuation of combination therapy was 2 years.
Whereby, the most common reason for discontinuation of combination
therapy was converting to single medication (19.8%). Age did not inﬂuence
the adherence rate (p < 0.484), but the QoL-I was a predictor to adherence
of combined therapy (p ¼ 0.000).
Conclusion: The patient received combination therapy showed signiﬁcant
improvement in all the measured parameter. The most common factor of
discontinuation of combination therapy was converting to single medi-
cation. QoL-I after treatment lead patient adheres to combination therapy.NDP039:
POSTOPERATIVE OUTCOMES AND SAFETY OF BIPOLAR TRANSURETHRAL
ENUCLEATION AND RESECTION OF THE PROSTATE
Kwun-Wai Chan, Chak-Lam Cho, Wing-Hong Chu, In-Chak Law. Divisions
of Urology, Department of Surgery, Kwong Wah Hospital, Hong Kong
Purpose: Bipolar transurethral enucleation and resection of the prostate
(TUERP) has been reported to be a method in the management of benign
prostatic hyperplasia (BPH), especially for large prostate glands. Our
objective was to report the early postoperative outcomes and safety of the
bipolar TUERP technique.
Materials and Methods: A total of 30 consecutive patients had undergone
bipolar TUERP by a single surgeon. All patients were evaluated preopera-
tively by physical examination, digital rectal examination, transrectal ul-
trasonography and blood tests, including haemoglobin, sodium level and
prostate speciﬁc antigen measurement. Patients were assessed peri-
operatively and postoperatively at 1, 3, 6 and 12 months.
Results: The mean enucleated prostatic adenoma specimen weight was
52.6g. The mean enucleation, resection and operative time were 13.6, 47.7
and 91.5 minutes respectively. The mean decrease in serum PSA after bi-
polar TUERP was 87.8% (from 6.36 to 0.86 ng/mL). Prostate volume was
decreased by 68.6% at 4 weeks postoperatively. The mean haemoglobin
drop was 1.18 g/dL. The rate of transient urinary incontinence at 3 month
was 3.6%. None of the patients required blood transfusion or developed
clot retention. One patient required re-catheterization and successfully
weaned off catheter 1 week later. Patients who underwent bipolar TUERP
had short catheterization time and hospital stay comparable to TURP
patients.
Conclusion: Bipolar TUERP is the safe and efﬁcient endourological
equivalent of open prostatectomy with fewer complications and shorter
convalescence. The technique of bipolar TUERP has a satisfactory early
functional outcomes and low morbidity.* Corresponding author.NDP040:
PREDICTIVE FACTORS TO URETHRAL STRICTURE AFTER TRANSURETHRAL
RESECTION OF PROSTATE
You-Chiuan Chien, Heng-Chieh Chiang, Bai-Fu Wang. Divisions of Urology,
Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan
Purpose: To evaluate the relationship between predictive factors and
urethral stricture (US) after transurethral resection of prostate (TUR-P).
Materials andMethods:We have retrospectively reviewed the data of 206
consecutive TUR-P cases by single experienced urologist. Eligible patients
(n ¼ 206) were grouped with respect to presence of US after TUR-P with
cystoscopy conﬁrmed 3 months after TURP; Group1: US positive (n ¼ 29,
14.1%), and Group2: US negative (n ¼ 177, 85.9%). Groups were compared
with respect to descriptive data.
Results: Of 206 eligible patients, lower post-OP (maximal uroﬂow rate)
UFRmax and lower pre-OP acute urine retention (AUR) were observed in
US positive group (17.1± 6.91 versus 11.37± 6.50, p < 0.01; 13.8% versus
35.0%, p ¼ 0.01, respectively). Other factors included age of the patient,
operation time, catheter indwelling days and prostate speciﬁc antigen
have no statistically signiﬁcant relation to US after TUR-P.
Conclusion: Post-OP UFRmax and UFRmax deviation are predictors of
post-OP urethral stricture. Pre-OP AUR is associated with post-OP urethral
stricture. Our results should be supported by prospective studies including
higher number of patients.NDP041:
RETROSPECTIVE EVALUATION OF THE LEARNING CURVE OF THE
THULIUM LASER ENUCLEATION OF THE PROSTATE: A SINGLE CENTER
EXPERIENCE
Chia-Lung Tsai 1, Ching-Yu Huang 1, Victor C. Lin 1,2. 1Department of
Urology, E-Da Hospital, Kaohsiung, Taiwan; 2 School of Medicine for
International Students, I-Shou University, Kaohsiung, Taiwan
Purpose: The aim of this article is to describe the learning curve of ThuLEP
(Thulium Laser Enucleation of Prostate) that permits a complete
anatomical endoscopic enucleation of prostatic adenoma independently to
prostate size.
Materials and Methods: 66 patients were enrolled between January 2013
and December 2014, and treated for BPH with ThuLEP. 24 patients were
excluded due to malignancy, infection, bladder stone, blood clot tampo-
nade and incomplete data. The following data of each patient was
collected: prostate volume, International Prostate Symptoms Score (I-PSS),
PSA value, total prostate volume, resected prostate weight, laser time.
ThuLEP was performed by a single surgeon. The data was reviewed
retrospectively.
Results: Mean age at surgery was 68.9+/-9.2 years. Mean preoperative size
of prostate was 79.8+/-26.8 ml Mean IPSS was 22.1+/-4.3. Mean resected
prostate weight was 28.2+/-17.2 gm. Mean operation time was 113.8+/-
34.5 minutes. Mean length of hospital day was 4.5+/-0.8 days. In the study,
enucleation efﬁciency including the ratio of prostate weight to laser time
and the ratio of resected prostate weight to total prostate volume was
gradually improved by practice. However, the P-value of the enucleation
efﬁciency was not signiﬁcant.
Conclusion: We shared our experience for the ThuLEP operation. ThuLEP
has a steep learning curve. Based on the available data, the approach is safe
and effective. Further, large-scale prospective studies are needed to prove
long-term durability.Urolithiasis
NDP042:
THE SEASONAL METEOROLOGICAL VARIATION ON UROLITHIASIS
Wei-Feng Ding, Hsu-Han Wang*, Sheng-Hsien Chu, Hsiao-Wen
Chen, Ta-Min Wang, Yang-Jen Chiang, Kuan-Lin Liu, Kuo-Jen
Lin. Division of Urology, Department of Surgery, Chang Gung Memorial
Hospital, Linkou, Taiwan
Purpose: The incidence of urolithiasis increases in warm climate region as
well as during summer months. The purpose of this study is to analysis the
impact of climate factors on the prevalence of urolithiasis in our hospital.
Materials and Methods: We retrospectively reviewed the records of
extracorporeal shockwave lithotripsy (ESWL) performed in our hospital
from January 2007 to December 2014. Total number of ESWL procedures
was recorded monthly during this 8-year period. Repeated ESWL of same
patient within one month was excluded and we only count as one ESWL in
our study. Total out-patient numbers at our hospital were used as an
estimation of population. Climate data of the corresponding months were
collected from Central Weather Bureau. Available monthly meteorological
data include highest, lowest and average temperature, average humidity,
total rainfall, total rain days, total sun-shine hours, average atmospheric
pressure and maximum 10-min wind speed.
Results: Monthly ESWL rate is positively associated with average tem-
perature (B ¼ 0.661, p < 0.001), rainfall (B ¼ 0.294, p ¼ 0.023), sun-shine
hours (B¼ 0.471, p < 0.001) andwind-speed (B¼ 0.310, p¼ 0.016); while it
is negatively related with humidity (B ¼ -0.378, p ¼ 0.003) and atmo-
spheric pressure (B ¼ -0.531, p < 0.001) in univariate linear regressions.
Whenwe examine these factors together in multivariate linear regression,
only monthly average temperature and atmospheric pressure remain
signiﬁcant association to ESWL rate. Using Poisson regression model, we
further validated that temperature (B ¼ 0.051, 95%CI: 0.034-0.068,
p < 0.001) and atmospheric pressure (B ¼ 0.029, 95%CI: 0.015-0.044,
